Journal
INTERNATIONAL UROGYNECOLOGY JOURNAL
Volume 30, Issue 3, Pages 371-376Publisher
SPRINGER LONDON LTD
DOI: 10.1007/s00192-018-3830-0
Keywords
Laser; Energy-based devices; Genitourinary syndrome of menopause; Vaginal laxity; Stress urinary incontinence; FDA
Categories
Ask authors/readers for more resources
This committee opinion reviews the laser-based vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, and stress urinary incontinence. The United States Food and Drug Administration has issued a warning for unsubstantiated advertising and use of energy-based devices. Well-designed case-control studies are required to further investigate the potential benefits, harm, and efficacy of laser therapy in the treatment of genitourinary syndrome of menopause, vaginal laxity, and stress urinary incontinence. The therapeutic advantages of nonsurgical laser-based devices in urogynecology can only be recommended after robust clinical trials have demonstrated their long-term complication profile, safety, and efficacy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available